0001231919-25-000123.txt : 20250718 0001231919-25-000123.hdr.sgml : 20250718 20250718124428 ACCESSION NUMBER: 0001231919-25-000123 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250718 DATE AS OF CHANGE: 20250718 EFFECTIVENESS DATE: 20250718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pahr Therapeutics, Inc. CENTRAL INDEX KEY: 0002077159 ORGANIZATION NAME: EIN: 332977903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-552238 FILM NUMBER: 251133502 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (781) 424-9384 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0002077159 Pahr Therapeutics, Inc. 200 BERKELEY STREET, 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 (781) 424-9384 DELAWARE None None Corporation true 2025 Neil Buckley c/o Pahr Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director Promoter Ken Horne c/o Pahr Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Amanda Creedon c/o Pahr Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Andrew Levin c/o Pahr Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Atsushi Usami c/o Pahr Therapeutics, Inc. 200 Berkeley Street, 18th Floor Boston MA MASSACHUSETTS 02116 Director Biotechnology Decline to Disclose 06b false 2025-02-27 false true false 0 14000002 4666668 9333334 Offer and sale of Series Seed Preferred Stock (and the Common Stock issuable thereunder) false 4 0 0 0 false Pahr Therapeutics, Inc. Neil Buckley Neil Buckley President 2025-07-07